153 related articles for article (PubMed ID: 28661993)
1. Commentary on The Clinical and Histological Effect of a Low-Fluence Q-Switched 1,064-nm Neodymium: Yttrium-Aluminum-Garnet Laser for the Treatment of Melasma and Solar Lentigenes in Asians.
Kauvar ANB
Dermatol Surg; 2017 Sep; 43(9):1134-1136. PubMed ID: 28661993
[No Abstract] [Full Text] [Related]
2. The Clinical and Histological Effect of a Low-Fluence Q-Switched 1,064-nm Neodymium: Yttrium-Aluminum-Garnet Laser for the Treatment of Melasma and Solar Lentigenes in Asians: Prospective, Randomized, and Split-Face Comparative Study.
Kaminaka C; Furukawa F; Yamamoto Y
Dermatol Surg; 2017 Sep; 43(9):1120-1133. PubMed ID: 28328709
[TBL] [Abstract][Full Text] [Related]
3. A randomized, split-face clinical trial of low-fluence Q-switched neodymium-doped yttrium aluminum garnet (1,064 nm) laser versus low-fluence Q-switched alexandrite laser (755 nm) for the treatment of facial melasma.
Fabi SG; Friedmann DP; Niwa Massaki AB; Goldman MP
Lasers Surg Med; 2014 Sep; 46(7):531-7. PubMed ID: 24895301
[TBL] [Abstract][Full Text] [Related]
4. A case of mottled hypopigmentation after low-fluence 1,064-nm Q-switched neodymium-doped yttrium aluminum garnet laser therapy.
Ryu HJ; Kim J
J Cosmet Laser Ther; 2013 Oct; 15(5):290-2. PubMed ID: 23464754
[TBL] [Abstract][Full Text] [Related]
5. Treatment of melasma in men with low-fluence Q-switched neodymium-doped yttrium-aluminum-garnet laser versus combined laser and glycolic acid peeling.
Vachiramon V; Sahawatwong S; Sirithanabadeekul P
Dermatol Surg; 2015 Apr; 41(4):457-65. PubMed ID: 25760554
[TBL] [Abstract][Full Text] [Related]
6. Induction of melasma by 1064-nm Q-switched neodymium:yttrium-aluminum-garnet laser therapy for acquired bilateral nevus of Ota-like macules (Hori nevus): A study on related factors in the Chinese population.
Wang B; Xie HF; Tan J; Xie HJ; Xu LY; Ding R; Liu FF; Chen X; Jian D; Li J
J Dermatol; 2016 Jun; 43(6):655-61. PubMed ID: 26777390
[TBL] [Abstract][Full Text] [Related]
7. Commentary on Clinical and Histopathological Assessment of Facial Melasma After Low-Fluence Q-Switched Neodymium-Doped Yttrium Aluminium Garnet Laser.
Morton LM
Dermatol Surg; 2016 Apr; 42(4):513-4. PubMed ID: 26949932
[No Abstract] [Full Text] [Related]
8. Treatment of melasma with low fluence, large spot size, 1064-nm Q-switched neodymium-doped yttrium aluminum garnet (Nd:YAG) laser for the treatment of melasma in Fitzpatrick skin types II-IV.
Brown AS; Hussain M; Goldberg DJ
J Cosmet Laser Ther; 2011 Dec; 13(6):280-2. PubMed ID: 21992660
[TBL] [Abstract][Full Text] [Related]
9. Low-fluence Q-switched neodymium-doped yttrium aluminum garnet laser for melasma with pre- or post-treatment triple combination cream.
Jeong SY; Shin JB; Yeo UC; Kim WS; Kim IH
Dermatol Surg; 2010 Jun; 36(6):909-18. PubMed ID: 20384749
[TBL] [Abstract][Full Text] [Related]
10. A randomized, observer-blinded, comparison of combined 1064-nm Q-switched neodymium-doped yttrium-aluminium-garnet laser plus 30% glycolic acid peel vs. laser monotherapy to treat melasma.
Park KY; Kim DH; Kim HK; Li K; Seo SJ; Hong CK
Clin Exp Dermatol; 2011 Dec; 36(8):864-70. PubMed ID: 21973194
[TBL] [Abstract][Full Text] [Related]
11. Formation of new melasma lesions in the periorbital area following high-fluence, 1064-nm, Q-switched Nd/YAG laser.
Lee WJ; Kim YJ; Noh TK; Chang SE
J Cosmet Laser Ther; 2013 Jun; 15(3):163-5. PubMed ID: 23656545
[TBL] [Abstract][Full Text] [Related]
12. Low-fluence Q-switched neodymium-doped yttrium aluminum garnet laser for melasma with pre- or post-treatment triple combination cream.
Draelos Z
Dermatol Surg; 2011 Jan; 37(1):126-7. PubMed ID: 21214668
[No Abstract] [Full Text] [Related]
13. Clinical and Histopathologic Assessment of Facial Melasma After Low-Fluence Q-Switched Neodymium-Doped Yttrium Aluminium Garnet Laser.
Hofbauer Parra CA; Careta MF; Valente NY; de Sanches Osório NE; Torezan LA
Dermatol Surg; 2016 Apr; 42(4):507-12. PubMed ID: 26963146
[TBL] [Abstract][Full Text] [Related]
14. The evolution of melasma therapy: targeting melanosomes using low-fluence Q-switched neodymium-doped yttrium aluminium garnet lasers.
Kauvar AN
Semin Cutan Med Surg; 2012 Jun; 31(2):126-32. PubMed ID: 22640433
[TBL] [Abstract][Full Text] [Related]
15. Long-term results in low-fluence 1064-nm Q-Switched Nd:YAG laser for melasma: Is it effective?
Gokalp H; Akkaya AD; Oram Y
J Cosmet Dermatol; 2016 Dec; 15(4):420-426. PubMed ID: 27349828
[TBL] [Abstract][Full Text] [Related]
16. Q-switched Nd: YAG laser versus trichloroacetic acid peeling in the treatment of melasma among Egyptian patients.
Moubasher AE; Youssef EM; Abou-Taleb DA
Dermatol Surg; 2014 Aug; 40(8):874-82. PubMed ID: 25068546
[TBL] [Abstract][Full Text] [Related]
17. Punctate leucoderma after 1,064-nm Q-switched neodymium-doped yttrium aluminum garnet laser with low-fluence therapy: is it melanocytopenic or melanopenic?
Kim T; Cho SB; Oh SH
Dermatol Surg; 2010 Nov; 36(11):1790-1. PubMed ID: 20961356
[No Abstract] [Full Text] [Related]
18. A low-fluence 1064-nm Q-switched neodymium-doped yttrium aluminium garnet laser for the treatment of café-au-lait macules.
Kim HR; Ha JM; Park MS; Lee Y; Seo YJ; Kim CD; Lee JH; Im M
J Am Acad Dermatol; 2015 Sep; 73(3):477-83. PubMed ID: 26169691
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of Q-switched 1,064-nm neodymium-doped yttrium aluminum garnet laser treatment of melasma.
Zhou X; Gold MH; Lu Z; Li Y
Dermatol Surg; 2011 Jul; 37(7):962-70. PubMed ID: 21615824
[TBL] [Abstract][Full Text] [Related]
20. Clinical efficacy of the dual-pulsed Q-switched neodymium:yttrium-aluminum-garnet laser: Comparison with conservative mode.
Kim BW; Lee MH; Chang SE; Yun WJ; Won CH; Lee MW; Choi JH; Moon KC
J Cosmet Laser Ther; 2013 Dec; 15(6):340-1. PubMed ID: 23789827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]